BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15155220)

  • 21. Tritrichomonas foetus: stable anaerobic resistance to metronidazole in vitro.
    Kulda J; Cerkasov J; Demes P; Cerkasovová A
    Exp Parasitol; 1984 Feb; 57(1):93-103. PubMed ID: 6692888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
    Leitsch D; Kolarich D; Duchêne M
    Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure of Tritrichomonas foetus to sublethal doses of metronidazole induces a specific proinflammatory response in murine macrophages.
    Ceballos-Góngora E; Torres-Romero JC; Arana-Argáez VE; Alvarez-Sánchez ME; Acosta-Viana K; Euan-Canto A; Alvarez-Sánchez LC
    J Eukaryot Microbiol; 2024; 71(1):e13000. PubMed ID: 37667470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Caatinga endemic Manilkara rufula possesses remarkable activity against Trichomonas vaginalis and Tritrichomonas foetus.
    de Brum Vieira P; Feijó Silva NL; Silva DB; Lopes NP; da Silva AG; da Silva MV; Bastida J; Macedo AJ; Tasca T
    Exp Parasitol; 2017 Feb; 173():18-28. PubMed ID: 27956086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tritrichomonas foetus: the role played by iron during parasite interaction with epithelial cells.
    Melo-Braga MB; da Rocha-Azevedo B; Silva-Filho FC
    Exp Parasitol; 2003 Oct; 105(2):111-20. PubMed ID: 14969688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-allose and D-psicose reinforce the action of metronidazole on trichomonad.
    Harada M; Kondo E; Hayashi H; Suezawa C; Suguri S; Arai M
    Parasitol Res; 2012 Apr; 110(4):1565-7. PubMed ID: 21960379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of solubilization vehicles for Trichomonas gallinae and Tritrichomonas foetus measured by the resazurin microtiter assay.
    Duarte M; Giordani RB; Carli GA; Zuanazzi JA; Macedo AJ; Tasca T
    Vet Parasitol; 2009 Dec; 166(1-2):167-70. PubMed ID: 19695781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of tinidazole for treatment of cats experimentally infected with Tritrichomonas foetus.
    Gookin JL; Stauffer SH; Coccaro MR; Poore MF; Levy MG; Papich MG
    Am J Vet Res; 2007 Oct; 68(10):1085-8. PubMed ID: 17916015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification, characterization, cloning and expression of pyruvate decarboxylase from Torulopsis glabrata IFO005.
    Wang Q; He P; Lu D; Shen A; Jiang N
    J Biochem; 2004 Oct; 136(4):447-55. PubMed ID: 15625313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing the open access malaria box reveals compounds with activity against Tritrichomonas foetus trophozoites.
    Martin KA; Jesudoss Chelladurai JRJ; Bader C; Carreiro E; Long K; Thompson K; Brewer MT
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():89-93. PubMed ID: 32734889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of transketolase and pyruvate decarboxylase by omeprazole.
    Nixon PF; Diefenbach RJ; Duggleby RG
    Biochem Pharmacol; 1992 Jul; 44(1):177-9. PubMed ID: 1632833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sialic acid-specific lectin-mediated adhesion of Tritrichomonas foetus and Tritrichomonas mobilensis.
    Babál P; Russell LC
    J Parasitol; 1999 Feb; 85(1):33-40. PubMed ID: 10207360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms underlying metronidazole resistance in trichomonads.
    Land KM; Johnson PJ
    Exp Parasitol; 1997 Nov; 87(3):305-8. PubMed ID: 9371098
    [No Abstract]   [Full Text] [Related]  

  • 36. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reassessment of the role of oxygen scavenging enzymes in the emergence of metronidazole resistance in trichomonads.
    Gehl V; Paunkov A; Leitsch D
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():38-44. PubMed ID: 33962363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and partial characterization of cytosolic malate dehydrogenase from Tritrichomonas foetus.
    Hrdý I
    Folia Parasitol (Praha); 1993; 40(3):181-5. PubMed ID: 8314175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of free radicals from metronidazole and other nitroimidazoles by Tritrichomonas foetus.
    Moreno SN; Mason RP; Muniz RP; Cruz FS; Docampo R
    J Biol Chem; 1983 Apr; 258(7):4051-4. PubMed ID: 6300071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the susceptibility of Trichomonas hominis to some abiotic factors. I. Preliminary assessment of antitrichomonal activity of selected compounds in vitro].
    Chomicz L; Zebrowska J; Zawadzki P; Myjak P; Perkowski K; Rebandel H; Kazimierczuk Z
    Wiad Parazytol; 2004; 50(3):405-9. PubMed ID: 16865945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.